Absci Corporation (ABSI)

CIK 0001672688 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-05-07) · 99.1 · 99.2
Latest FY-2025 8-K (2026-03-24) · 99.1 · 99.2
Q3-2025 8-K (2025-11-12) · 99.1 · 99.2
Q2-2025 8-K (2025-08-12) · 99.1 · 99.2
Q1-2025 8-K (2025-05-13) · 99.1 · 99.2
FY-2024 8-K (2025-03-18) · 99.1 · 99.2
Q3-2024 8-K (2024-11-12) · 99.1 · 99.2
Q2-2024 8-K (2024-08-14) · 99.1 · 99.2
Q1-2024 8-K (2024-05-14) · 99.1
FY-2023 8-K (2024-03-21) · 99.1  |  8-K (2024-02-27)
Q3-2023 8-K (2023-11-14) · 99.1 · 99.2
Q2-2023 8-K (2023-08-14) · 99.1 · 99.2
FY-2022

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Audit Information
—
Statements
Unaudited Condensed Consolidated Balance Sheets
—
Consolidated Balance Sheets
—
Unaudited Condensed Consolidated Balance Sheets (P)
—
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss
—
Consolidated Balance Sheets (P)
—
Consolidated Statements of Operations and Comprehensive Loss
—
Unaudited Statements of Changes In Stockholders Equity
—
Statements of Changes In Stockholders Equity
—
Unaudited Condensed Consolidated Statements of Cash Flows
—
Unaudited Statements of Changes In Stockholders Equity (P)
—
Statements of Changes In Stockholders Equity (P)
—
Consolidated Statements of Cash Flows
—
Notes
Accounts Payable and Accrued Expenses
Collaborative Arrangements
Commitments and Contingencies
Common Stock
Cybersecurity Risk Management and Strategy Disclosure
—
Employee Benefit Plans
—
Fair Value Measurements
Goodwill and Intangibles, Net
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangibles, Net
—
Investments
Leases
—
Long-term Debt and Other Borrowings
Net Loss Per Share
Organization and Nature of Operations
Pay Vs Performance Disclosure
Property and Equipment, Net
Revenue Recognition
Segment Reporting
Stock-based Compensation
Subsequent Events
Summary of Significant Accounting Policies